来自人类羊水干细胞的细胞外囊泡改善了糖尿病动脉样硬化的老鼠模型中的膀功能障碍
Ching-Chung Liang1,2, Yi-Hao Lin1,2, Chu-Ya Liang3
1Female Urology Section, Department of Obstetrics and Gynecology, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan.
World journal of stem cells
|January 29, 2026
概括
人类胚胎液干细胞衍生的细胞外囊泡 (hAFSC-EVs) 对大鼠糖尿病动脉样硬化引起的膀功能障碍具有治疗潜力. 通过减少炎症和动脉壁厚度,治疗改善了膀功能.
科学领域:
- 再生医学是一种再生医学.
- 血管生物学 血管生物学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 糖尿病动脉样硬化 (DMA) 的发病率在全球范围内不断上升,其致病源不明.
- 膀功能障碍是DMA的常见,治疗不耐药的并发症.
研究的目的:
- 评估人类羊水干细胞衍生的细胞外囊泡 (hAFSC-EVs) 在DMA诱导的膀功能障碍的小鼠模型中的治疗疗效.
主要方法:
- 鼠被分为对照,糖尿病,DMA和DMA,接受了 hAFSC-EVs的治疗.
- 评估的参数包括血糖,脂质概况,胰岛素抵抗标记,囊泡测量,动脉壁厚度和炎症标记 (TNF-α,IL-6,TGF-β1,Smad3,CTGF).
主要成果:
- 在DMA小鼠中,膀重量,血糖,动脉厚度和炎症标志物增加,同时HOMA-β和HDL胆固醇降低.
- hAFSC-EVs治疗显著改善了膀功能障碍,降低了血糖和动脉内脏厚度.
- 在DMA大鼠中,治疗降低了TNF-α,TGF-β1,CTGF,IL-6和Smad3的mRNA表达.
结论:
- hAFSC-EV证明了DMA诱导的膀功能障碍的治疗潜力.
- 治疗的好处与改善血糖控制,减少动脉加厚和抑制炎症途径有关.
相关概念视频
The Fluid Mosaic Model
177.8K
The fluid mosaic model was first proposed as a visual representation of research observations. The model comprises the composition and dynamics of membranes and serves as a foundation for future membrane-related studies. The model depicts the structure of the plasma membrane with a variety of components, which include phospholipids, proteins, and carbohydrates. These integral molecules are loosely bound, defining the cell’s border and providing fluidity for optimal function.
177.8K
Embryonic Stem Cells
32.4K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.4K
Fluid Mosaic Model
16.0K
Scientists identified the plasma membrane in the 1890s and its principal chemical components (lipids and proteins) by 1915. The model for plasma membrane structure, proposed in 1935 by Hugh Davson and James Danielli, was the first model to be widely accepted in the scientific community. The model was based on the plasma membrane's "railroad track" appearance in early electron micrographs. Davson and Danielli theorized that the plasma membrane's structure resembled a sandwich...
16.0K
Atherosclerosis III: Management
398
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
398
The Extracellular Matrix
88.9K
Overview
88.9K
Atherosclerosis I: Introduction
1.1K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.1K


